SCHEMBL7770916

SCHEMBL7770916

CC(=O)NC1CC(=O)N(O)C1=O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.38
KDM4E B2RXH2 4/20 0.36
TACR1 P25103 2/20 0.33
TLR4 O00206 1/20 0.32
ALDH1A1 P00352 4/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
MAPT P10636 2/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
THRB P10828 1/20 0.30
HSD17B10 Q99714 1/20 0.30
BRD4 O60885 1/20 0.30
PTGDR2 Q9Y5Y4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13248612 0.81 CYP1A2 (0.47) HTR1AKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL21895951 0.81 CYP1A2 (0.47) HTR1AKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL16925898 0.78 ALDH1A1 (0.33) KDM4EALDH1A1CYP1A2CYP3A4MAPT
SCHEMBL7767003 0.77 KDM4E (0.40) KDM4EALDH1A1LMNA
SCHEMBL19261635 0.73 ALDH1A1 (0.34) KDM4EALDH1A1MAPTPOLBTDP1
SCHEMBL8255873 0.73 GAA (0.33)
SCHEMBL1518987 0.71 ADAM17 (0.32) ALDH1A1MAPTPOLBTDP1
SCHEMBL9636282 0.69 SMN1; SMN2 (0.64) HTR1AKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL2239318 0.67
Acetic Acid SCHEMBL6802327 0.67 MT-CO2 (0.32) MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854860-B1 A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME CIE DE DEV AGUETTANT (FR) 2001-07-25 EP claimed
EP-0854860-A1 A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) 1998-07-29 EP claimed
US-5705522-A D-ACETAMIDO-N-HYDROXY SUCCINAMIC ACID DERIVATIVES; AIDS, HIV INFECTIONS COMPAGNIE DE DEVELOPPEMENT AGUETTANT S.A. (FR) 1998-01-06 US claimed
WO-1997010205-A1 A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) 1997-03-20 WO claimed
EP-0854860-B1 A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME CIE DE DEV AGUETTANT (FR) 2001-07-25 EP disclosed
EP-0854860-A1 A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) 1998-07-29 EP disclosed
US-5705522-A D-ACETAMIDO-N-HYDROXY SUCCINAMIC ACID DERIVATIVES; AIDS, HIV INFECTIONS COMPAGNIE DE DEVELOPPEMENT AGUETTANT S.A. (FR) 1998-01-06 US disclosed
WO-1997010205-A1 A NEW FAMILY OF COMPOUNDS HAVING ANTI-INFLAMMATORY AND ANTI-VIRAL ACTIVITY AND COMPOSITIONS OF THESE, ALONE AND IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS, FOR INHIBITING, PREVENTING OR ELIMINATING VIRAL REPLICATION AND METHODS OF USING SAME COMPAGNIE DE DEVELOPPEMENT AGUETTANT (FR) 1997-03-20 WO disclosed